Managed Access Programs for CTL019, Tisagenlecleucel
Clinical trial NCT03601442 · AVAILABLE
Trial details
- NCT number
- NCT03601442
- Sponsor
- Novartis Pharmaceuticals
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.